COMOGLIO PAOLO MARIA,Comoglio Paolo Maria,BOCCACCIO CARLA,Boccaccio Carla,PETRONZELLI FIORELLA,Petronzelli Fiorella,DE SANTIS RITA,De Santis Rita
申请号：
SI201130217
公开号：
SI2500036T1
申请日:
2011.03.18
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
Met inhibitor and/or nucleotide sequence encoding a Met inhibitor for use in the treatment of patients suffering from a cancer for reducing and/or abrogating patients resistance to radiotherapy, wherein the Met inhibitor is selected among: i) an anti-Met monoclonal antibody, ii) a genetically engineered antibody containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, and iii) a fragment of (i) or (ii) containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, or combinations thereof.
